Default company panoramic image
1b94c994 eac1 4105 a697 0e82ed4f3924

SOEMS Corporation

SOEMS' clinical stage technology increases collagen and elastin in the dermis and epidermis, naturally rejuvenating and healing the skin.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Watchung, NJ, USA
  • Currency USD
  • Founded December 2001
  • Employees 1
  • Website

Company Summary

In a survey, a Dermatologist claimed that “Every woman over 50 would be given this…” We restore youth and beauty to our customer's skin and remove the ravages of photoaging and intrinsic aging. Our novel phase 1--2 programs have broad applications for new products for cosmetics and pharmaceuticals for dermatology. According to NHANES data 15 percent of all women over 45 would require this product.


  • Default avatar
    Thomas Lavin

    President Thomas Lavin is a Board Certified (Internal Medicine) Medical Doctor, a Biochemist, and serial entrpreneur. Dr. Lavin is a former university faculty endocrinologist at UC San Francisco, Duke, and Cornell. Dr. Lavin has served as a chairperson for national scientific meetings and worked as a reviewing editor for Science magazine, the Journal of Biological Science and other academic publications.

  • Default avatar
    Richard Baker
    Business Development

    Rich Baker handles Business Development issues for SOEMS Corporation. He is also the President of New England Intellectual Property, LLC, an IP consulting firm. Mr. Baker spent 6 years as the Director of Intellectual Property for 3Com Corporation. Rich also spent 20 years at Schneider Electric as Director of Intellectual Property and in various engineering and program management positions. He is a Trustee for the Licensing Exec Soc.

Previous Investors

  • Default avatar
    Dr. Thomas Lavin